MedPath

The investigation for the effects of Ti-Luo Hua-Yu Yang-Xue Ming-Mu method on the eyeground blood flow of the NTG patients

Not Applicable
Conditions
normal tension glaucoma
Registration Number
ITMCTR1900002799
Lead Sponsor
China Academy of Chinese Medical Sciences Eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Part one inclusion criteria:
Inclusion criteria for Normal control group:
1. the best corrected visual acuity (BCVA) > 0.8;
2. IOP <21 mmHg;
3. The eyeground is normal, C/D is normal. OCT shows normal RNFL thickness and normal visual field;
4. Aged 20 and 75 years.
Inclusion criteria for HTG group:
1. meet the diagnostic criteria;
2. Aged between 20 and 75 years;
Inclusion criteria of NTG group:
1. meet the diagnostic criteria and the TCM Syndrome Diagnostic Criteria;
2. Ages between 20 and 75 years;
3. After lowering intraocular pressure drug therapy, intraocular pressure stabilized below 15mmHg for more than 2 months.
Part two inclusion criteria:
1. meet the diagnostic criteria and the TCM Syndrome Diagnostic Criteria;
2. Ages between 20 and 75 years;
3. After lowering intraocular pressure drug therapy, intraocular pressure stabilized below 15mmHg for more than 2 months.

Exclusion Criteria

Part one exclusion criteria:
Exclusion criteria for control group:
1. family history of glaucoma;
2. diopter greater than + 3.00d or less than -8.00d;
3. patients with serious systemic diseases such as heart failure, liver and kidney dysfunctions, gastric and duodenal ulcers, diabetes mellitus and malignant hypertension. Serum creatinine > 2 times upper limit of normal value (ULN); Serum glutamine transaminase > 3 times ULN;
4. History of eye surgery or trauma;
5. Mental illness or anxiety, depression and other abnormal psychological state and malignant tumors;
6. Pregnant or nursing women;
7. Failing to follow doctor's advice and cooperate with relevant examinations.
Exclusion criteria for NTG and HTG group:
1. Fixation loss > 20%;
2. Diopter between + 3.00d and -8.00d;
3. The false-positive or false-negative rate of visual field tested by Humphrey is greater than 33;
4. Patients with malignant tumors;
5. History of eye surgery or trauma;
6. In the past 1 month, have used traditional Chinese medicine or western medicine of vasodilator and neuroprotective drugs;
7. Suspicious or definite allergy to the study drug;
8. Serum creatinine > 2 ULN;
9. Serum glutamine transaminase > 3 ULN;
10. History of eye surgery or trauma;
11. Patients with heart Yang deficiency syndrome are mainly manifested by chest tightness and chest pain, palpitations and cold sweat, and aversion to cold limbs;
12. Mental illness or anxiety, depression and other abnormal psychological state and malignant tumors;
13. Participated in other clinical trials in the last 3 months;
14. Pregnant or nursing women;
15. Failing to follow doctor's advice and cooperate with relevant examinations.
Part two exclusion criteria:
Exclusion criteria for NTG and HTG group:
1. Fixation loss > 20%;
2. Diopter between + 3.00d and -8.00d;
3. The false-positive or false-negative rate of visual field tested by Humphrey is greater than 33;
4. Patients with malignant tumors;
5. History of eye surgery or trauma;
6. In the past 1 month, have used traditional Chinese medicine or western medicine of vasodilator and neuroprotective drugs;
7. Suspicious or definite allergy to the study drug;
8. Serum creatinine > 2 ULN;
9. Serum glutamine transaminase > 3 ULN;
10. History of eye surgery or trauma;
11. Patients with heart Yang deficiency syndrome are mainly manifested by chest tightness and chest pain, palpitations and cold sweat, and aversion to cold limbs;
12. Mental illness or anxiety, depression and other abnormal psychological state and malignant tumors;
13. Participated in other clinical trials in the last 3 months;
14. Pregnant or nursing women;
15. Failing to follow doctor's advice and cooperate with relevant examinations.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual field;optic disc blood flow;Angle of loss of optic nerve fiber layer;vision;upstream blood supply of eye;Thickness of optic nerve fiber layer;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath